The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma

Background and Objectives: The impact of direct-acting antiviral (DAA)-based regimens on the recurrence of hepatocellular carcinoma (HCC) after successful curative hepatectomy is controversial. Aims: This study aimed to assess the association between DAAs treatment and recurrence risk in HCC after r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Syuan, Huang, Kuo-Hsuan, Wang, Pei-Ming, Chuang, Ching-Hui, Yong, Chee-Chien, Liu, Yueh-Wei, Huang, Pao-Yuan, Yao, Chih-Chien, Lin, Yen-Po, Tsai, Ming-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875284/
https://www.ncbi.nlm.nih.gov/pubmed/35208582
http://dx.doi.org/10.3390/medicina58020259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875284/
https://www.ncbi.nlm.nih.gov/pubmed/35208582
http://dx.doi.org/10.3390/medicina58020259

Ejemplares similares